Document Detail


Prevalence of and risk factors for pre-diabetes in HIV-1-infected patients in Bangkok, Thailand.
MedLine Citation:
PMID:  21075913     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Pre-diabetes substantially increases the risk of developing macrovascular complication and progression to diabetes. This study aimed to determine the prevalence of and risk factors for pre-diabetes in HIV-1-infected patients. A cross-sectional study was conducted in HIV-1-infected patients who visited the infectious diseases clinic in a university hospital. Fasting plasma glucose (FPG) was performed. There were 149 patients, mean age 42.2 years, and 65.1% were males. Median CD4 count was 434 cells/mm(3). In total, 92% have received antiretroviral therapy (ART), with a median duration of 0.8 years. The prevalence of pre-diabetes was 27.5%. From multivariate analysis, body weight ([BW] per 5 kg increase, odds ratio [OR] = 1.241; 95% confidence interval [CI], 1.014-1.518; P = .036) and, tentatively, male gender (OR = 2.906; 95% CI, 0.941-8.976; P = .064) were risk factors for pre-diabetes. Nevirapine (NVP) use (OR = 0.383; 95% CI, 0.161-0.910; P = .030) was a protective factor for pre-diabetes. Pre-diabetes is common in HIV-1-infected patients receiving ART. Screening for pre-diabetes and active management should be performed in patients with risk factors.
Authors:
Nopporn Srivanich; Chardpraorn Ngarmukos; Somnuek Sungkanuparph
Related Documents :
9351073 - Poor pre-dialysis glycaemic control is a predictor of mortality in type ii diabetic pat...
1830313 - Lipoproteins and diuretics in type ii diabetes.
15271063 - Oestradiol restores cell proliferation in dentate gyrus and subventricular zone of stre...
Publication Detail:
Type:  Journal Article     Date:  2010-11-12
Journal Detail:
Title:  Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)     Volume:  9     ISSN:  1545-1097     ISO Abbreviation:  J Int Assoc Physicians AIDS Care (Chic)     Publication Date:    2010 Nov-Dec
Date Detail:
Created Date:  2010-12-08     Completed Date:  2011-02-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101185740     Medline TA:  J Int Assoc Physicians AIDS Care (Chic)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  358-61     Citation Subset:  IM    
Affiliation:
Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Anti-HIV Agents / adverse effects,  pharmacology*
Cross-Sectional Studies
Female
HIV Infections / drug therapy*,  epidemiology*
HIV-1*
Humans
Logistic Models
Male
Multivariate Analysis
Nevirapine / adverse effects,  pharmacology*
Prediabetic State / chemically induced,  epidemiology*
Prevalence
Risk Factors
Thailand / epidemiology
Chemical
Reg. No./Substance:
0/Anti-HIV Agents; 129618-40-2/Nevirapine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pilot study: does lower extremity night splinting assist in the management of painful peripheral neu...
Next Document:  Adherence to antiretroviral therapy in an urban, free-care HIV clinic in Guatemala City, Guatemala.